Monocytes are key contributors in various inflammatory disorders and alterations to these cells, including their subset proportions and functions, can have pathological significance. An ideal method for examining alterations to monocytes is whole blood flow cytometry as the minimal handling of samples by this method limits artifactual cell activation. However, many different approaches are taken to gate the monocyte subsets leading to inconsistent identification of the subsets between studies. Here we demonstrate a method using whole blood flow cytometry to identify and characterize human monocyte subsets (classical, intermediate, and non-classical). We outline how to prepare the blood samples for flow cytometry, gate the subsets (ensure contaminating cells have been removed), and determine monocyte subset expression of surface markers -in this example M1 and M2 markers. This protocol can be extended to other studies that require a standard gating method for assessing monocyte subset proportions and monocyte subset expression of other functional markers.
Introduction
Monocytes are a type of white blood cells which play a major role in promoting and resolving inflammation. There are three main subsets of monocytes recognized, classical (~85%), intermediate (~5%), and non-classical (~10%) monocytes, which are characterized by their level of cluster of differentiation (CD)14 and CD16 expression 1 . The proportions of monocyte subsets can differ with the presence of disease, such as an increased proportion of intermediates in various inflammatory states 2, 3 including cardiovascular disease, where the level of intermediates is associated with clinical events 4, 5 . Furthermore, in disease conditions, monocytes can also undergo functional changes, with many changes detectable by a difference in surface marker expression 6, 7 . One such example is monocyte M1-skewing, an increase in markers associated with M1 macrophages, which has been observed in cardiovascular disease, diabetes, obesity, and metabolic syndrome 7, 8, 9, 10 . Despite the popularity of flow cytometry to assess monocyte subset proportion and function, there is a considerable variability in sample preparation and subset gating between studies which makes it difficult to compare findings between such studies. Importantly, there is no consensus in the demarcation of monocyte subsets, yet a standardized approach is essential given the clinical significance of changes in subset proportions in several diseases. Part of the difficulty in gating arises from the fact that monocytes differentiate from the classical through the intermediate to the non-classical subset 11 and as such, monocytes exist as a continuous spectrum rather than distinct populations 12 . Interestingly, Zawada et al. showed that using either a rectangular or trapezoid gating of the intermediate subset, both resulted in a higher intermediate subset that predicted a cardiovascular endpoint 13 . This highlights that, at least for calculating proportions, the key issue is applying a consistent gating strategy between different samples (and studies), rather than attempting to definitively discriminate between subsets. While definitive gating may be more important when assessing function, the change in marker expression between subsets is incremental 1. Open files in the analysis software. Double click tube name and select parameters from the dropdown menus to visualize the cells on a forward scatter area FSC(A)/forward scatter height FSC(H) plot. Create a doublet exclusion gate by clicking on the polygon gate tool icon and enclosing the cells as in (Figure 1A ). 2. Select the gated cells (by double clicking on the gated region) and in the new display box adjust dropdown menu parameters to display the cells on an FSC(A)/side scatter SSC(A) plot. Click on the rectangular gate icon and generously select the monocyte population based on forward and side scatter properties to exclude the majority of lymphocytes, NK cells, and granulocytes ( Figure 1B ). 3. Select the gated cells and redisplay on a CD14/CD16 plot, selecting the parameters by using the dropdown menus. Click on the polygon gate to select monocytes based on their characteristic "┐" shape ( Figure 1C ). 4. Select the gated cells and display the monocytes on a CD16/HLA-DR plot by using the dropdown menus to select parameters. Click on the polygon gate to select the HLA-DR positive cells and exclude any remaining NK cells and neutrophils 17 ( Figure 1D ).
5.
Select the gated cells and display the HLA-DR positive cells on a CD14/HLA-DR plot using dropdown menus to select parameters. Click on the polygon gate and draw a gate to exclude the HLA-DR high/CD14 low cells (B cells express high levels of HLA-DR but not CD14) ( Figure  1E) . NOTE: B cell contamination may occur and therefore should be investigated. If the non-classical population in Figure 1C is not distinct from the cells to its left, then contamination is likely.
Step 3.5 can be skipped if B cells are not overlapping with non-classical monocytes. 6. Select the gated cells and use dropdown menus to display them on a CD16/CD14 plot. From plot options select "Zebra plot" which will enable monocyte subset gates to be drawn to determine subset proportions ( Figure 1F) . NOTE: If zebra plot is unavailable on the analysis software, pseudo color (smooth) or contour plot may be suitable. 7. Click on the rectangular gate icon and select the classical monocytes by drawing an approximate rectangular gate around the CD14 high/ CD16 low, classical monocyte population. Under "Display" select "Show medians" to display the median fluorescence intensity for classical monocytes. Adjust the gate such that the population has an equal distribution from the median on the left and right encompassing all the cells to the left. 
Phenotypic Monocyte Marker Expression
1. Select cells from each monocyte subset. Alter dropdown parameters to create a histogram for each monocyte subset ( Figure 1F ) displaying each marker and its matching isotype (Figure 4 ). 2. Calculate the degree of expression of each marker (median or geometric mean) compared to the respective isotype control.
Representative Results
The monocyte gating strategy and flow cytometry analysis used here (Figure 1 ) successfully gated the monocyte subsets and revealed their relative proportions. The proportions (for this sample) were calculated as 88.1% classicals, 4.33% intermediates, and 7.49% non-classicals. These subset gates were not contaminated with B cells, T cells, neutrophils or NK cells, which was confirmed with markers CD19, CD3, CD56, and CD66b, respectively. By assessing the relative position of other populations, it is clear that the T cells and neutrophils fall well outside the monocyte "┐" shape on a CD16/CD14 plot (Figure 2A and 2D) . However, both the NK cells and B cell populations overlapped with the nonclassical monocyte population (Figure 2B and 2C) . The steps of the gating strategy ( Figure 1D and 1E) were confirmed to exclude the NK cells ( Figure 3A) and B cells (Figure 3B) . Although the B cell population included a small portion of non-classical monocytes, the amount was negligible. 
Discussion
Whole blood flow cytometry is an ideal approach to study monocytes as the cells are examined in conditions close to their physiological microenvironment providing an insight into their roles in infection and inflammatory conditions. Furthermore, the use of fresh (i.e., unprocessed) blood samples minimizes the alterations or cell transformations that can occur due to storage or handling 18, 19 , such as those known to occur with freeze-thawed monocytes 20 . Prompt sample preparation is recommended as some markers are upregulated if samples are kept at room temperature prior to processing 19 . The optimal concentrations of M1 and M2 markers were determined by titration, and this should be done for any new antibody to limit non-specific binding whilst ensuring that the degree of shift is due to antigen expression and not restricted by lack of antibody. The removal of red blood cells and fixation of white blood cells with lysis solution is an important step in this protocol as the presence of red blood cells can interfere with flow cytometry 21, 22 . Note that while some lysis solutions are compatible with no-wash staining, clearer populations are evident in our hands when a wash step is used.
Correct setup of the flow cytometer is also critical when comparing expression of monocyte markers. We recommend that researchers maintain consistent target fluorescence intensities of control beads and perform quality control on the instrument to be used to provide consistent results across different samples run on different days. In addition to this, isotype controls are used to assist in interpreting any non-specific background signal generated by non-specific antibody binding. Monocytes have high levels of Fc receptors 11 and therefore are prone to non-specific binding.
Of note, the level of non-specific binding differs for the different subsets, and thus the use of an isotype control becomes important when comparing the degree of marker expression between subsets.
Another important criterion to be considered is the gating steps employed. Some studies suggest that it is crucial to draw a tight gate around the monocyte population in FSC(A)/SSC(A) plot to get rid of most of the non-monocytic CD16 positive cells 23, 24, 25 , but this may lead to loss of some monocytes as non-monocyte cells can overlap with monocytes on FSC/SSC plots 26 . Rather, to exclude any other blood cells that may contaminate the monocytes, the inclusion of a third monocyte marker in addition to CD14 and CD16, is essential 26, 27 . For this reason, HLA-DR is often used and is ideal as it is not expressed by NK cells or neutrophils 17, 28 . Although lymphocytes (B cells and T cells) may express HLA-DR, they differ from monocytes in respect to CD14 expression. While HLA-DR is an ideal third marker, CD86 has also been recommended 5,27,29 but
was not used here as it is also an M1 marker and thus its degree of expression on monocyte subsets was assessed.
Validation of the gating strategy used is of crucial importance. While NK cells are known to overlap with non-classicals if they are not gated out 28 There are also many different ways in which the gates for the monocytes themselves have been drawn in the literature; these include quadrants (the subsets are separated by quadrant markers), and rectangular or trapezoid boxes 13 (with separate boxes drawn for each subset) which furthermore differ in their placement delineating where one subset ends and another starts. These differences likely reflect the fact that monocytes exist as a continuum of cells, differentiating from classical to non-classical, rather than as clearly distinct populations. However, because variations in techniques for identifying the subsets themselves can lead to differences in the calculated monocyte subset proportions, it becomes important that the gating method is reasonably objective, rather than subjective, as this will make the method more robust and reproducible. Some studies use an isotype control for CD16 to determine the border between the classical and intermediate subsets 30 . On the other hand, to define the separation between intermediates and non-classicals, it has been proposed that the cut-off line may be vertical or oblique, with the choice up to the investigators, the proviso being it should be reproducible, but a rectangular gate has been recommended to facilitate comparisons between studies 13, 30, 31 . Here, increased objectiveness was obtained by plotting the data on a zebra plot and applying objective visual rules, because zebra plots provide an additional visualization cue by mixing color gradient to each equal probability bin over a traditional contour plot. The right border of the classical subset was drawn such that the population was evenly distributed around the population median. The division between the intermediates and non-classicals were also standardized by having the base of the intermediates align with the bottom of the concentric circles within the classical population (i.e., the intermediate population clearly expresses high levels of CD14, as per the standard nomenclature 1 ).
While some studies have suggested the use of additional markers, such as C-C chemokine receptor type 2 (CCR2) or 6-sulfo LacNAc (SLAN) for obtaining successful enumeration of monocytes and to reveal their clinical significance 32, 33 , in our hands the level of expression of many monocyte functional markers varies widely between individuals 14 . Such variation may limit the usefulness of these markers to define subsets based on their expression. Automated computational approaches have also been used to visualize and cluster monocyte subsets including visual interactive stochastic neighbor embedding (viSNE), t-distributed stochastic neighbor embedding (tSNE), or Spanning-tree Progression Analysis of Density-normalized Events (SPADE) 34, 35 , which can provide visual representation of the cells based on the set of multiple markers used. While this has been shown to increase the accuracy of the gating strategy in monocyte subset classification, it is recognized that a drawback is the number of antibodies (and corresponding fluorophore channels) required. Its usefulness will depend on the questions being asked; the extra complexity may not be warranted, for example, in enumeration studies.
Monocytes gated with our technique show proportions in line with the literature and the expression of surface markers by the three subsets can be readily determined. Overall, the technique and methodology explained here provides a standardized and straightforward method of enumerating monocyte subset proportions and assessing surface marker expression, which can be extended to include other markers as well, thereby validating their functional roles in various other conditions.
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